Clinical trial
Japan Morning Surge-1 Study
NCT00285519 · Japan Heart Foundation, Other · Completed
Key facts
| NCT number | NCT00285519 |
|---|---|
| Title | Japan Morning Surge-1 Study |
| Official title | The Effects of Controlling Morning Hypertension on Target Organ Damage With Adrenergic Blockers, Based on Self-Measured Morning Blood Pressure Readings |
| Lead sponsor | Japan Heart Foundation, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Doxazosin (drug) |
| Enrollment | 600 |
| Start date | Aug 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Feb 2, 2006 |
| Last update posted | Feb 2, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: